ReviewDrug design, development and therapy2017

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale.

Sayf A Yassin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.